The healthcare sector in the United States has seen many changes in recent years, largely due to legislation focused on improving patient care and boosting innovation. A key piece of legislation is the 21st Century Cures Act, which became law on December 13, 2016. This act plays an important role in American health by streamlining medical product development, improving health data sharing, and preventing “information blocking.”
The Cures Act aims to speed up medical product development and improve patient access to new treatments. It emphasizes the value of incorporating patient feedback in the design and regulatory processes for drugs, biological products, and medical devices. The act establishes expedited pathways like the Regenerative Medicine Advanced Therapy (RMAT) and the Breakthrough Devices program, which help bring new therapies and technologies to market faster.
This act provides funding of $500 million over nine years, allowing the Food and Drug Administration (FDA) to support these initiatives. This funding is vital for the FDA to update clinical trial designs by using real-world evidence and actual patient outcomes, speeding up the review and approval process for new products. Collaboration between the FDA and various stakeholders has led to better patient therapies.
Additionally, the Act allocates $4.8 billion for the National Institutes of Health (NIH) over ten years to promote data sharing and collaboration among researchers. This funding helps reduce administrative burdens that can delay clinical trials, leading to quicker access to new medical treatments.
A primary goal of the Cures Act is to improve health data interoperability. Traditionally, sharing patient data across healthcare systems has not been efficient, resulting in fragmented care and higher medical costs. The Cures Act highlights the importance of smooth health information sharing among stakeholders to enhance patient care quality.
The Cures Act includes measures to address issues in data sharing. It outlines certain exceptions where information blocking does not apply. Healthcare providers must ensure that patients can access their health information electronically without unreasonable barriers or costs. This requirement promotes transparency and encourages patients to take an active role in their care.
To improve patient data access, the Office of the National Coordinator for Health Information Technology (ONC) has set standards for use across the healthcare sector, requiring the adoption of standardized application programming interfaces (APIs). These APIs allow patients to securely connect to their electronic health information (EHI) through mobile applications, increasing access to important health data, including claims and clinical information.
Healthcare providers now must allow patients to access all of their EHI—both structured and unstructured—at no cost. By improving access to health data, the Cures Act supports patients in making informed decisions, leading to better health outcomes.
The Cures Act builds on existing processes established by the Health Information Technology for Economic and Clinical Health (HITECH) Act and introduces new initiatives to encourage innovation. The ONC’s Cures Act Final Rule is a notable part of this regulatory framework, focusing on secure access and use of electronic health information.
While encouraging data sharing, the Cures Act emphasizes the importance of protecting patient privacy. Efforts to prevent data breaches through strict regulations can boost patients’ confidence, which is critical for the success of health initiatives. Research indicates that healthcare accounted for 28.5% of all data breaches in 2020, highlighting the need for effective compliance measures.
Compliance with the Cures Act is a key focus for medical administrators and IT managers. Key regulations include:
The financial penalties for non-compliance can be severe; HIPAA violations can result in fines ranging from $100 to $50,000 for each violation depending on the negligence level. This creates a strong incentive for administrators to comply with the regulations in the Cures Act.
Despite these measures, challenges still exist in implementing the Cures Act provisions. Integration costs remain high, with many EHR vendors charging fees that can exceed $700,000 annually for system access. This cost is a significant barrier for third-party developers trying to enhance patient care.
Discussions continue on the need for regulatory changes to address these integration fees. Possible solutions include:
Solving these financial barriers will promote innovation in healthcare technology, allowing new and established organizations to respond better to patient needs.
The Cures Act’s support for innovation and data sharing highlights the growing role of artificial intelligence (AI) in healthcare. AI can help automate administrative tasks and improve patient interactions. Companies like Simbo AI are leading these changes by applying AI to enhance healthcare communication systems.
AI can streamline administrative tasks like appointment scheduling and patient follow-ups. This efficiency not only boosts operational effectiveness but also enhances patient engagement. By automating repetitive tasks, healthcare professionals can focus more on providing quality care and building relationships with patients.
Healthcare practices that implement AI can better manage compliance with healthcare regulations. Intelligent data management systems can automatically classify and secure patient data, reducing the risk of breaches and related compliance challenges. This combination of automation and data management aligns with the Cures Act’s objectives, promoting secure and efficient data sharing to ensure safe patient care.
Using AI in healthcare processes opens many opportunities to improve patient care. For example, predictive analytics can offer valuable information about patient populations, helping providers make better decisions about preventive care and treatment options. By analyzing past data, AI can identify patients at risk and facilitate timely intervention, improving health outcomes.
The 21st Century Cures Act is important in shaping the future of healthcare in the United States, focusing on patient access to information and new therapies. It’s crucial for medical practice administrators, owners, and IT managers to understand the provisions of the Cures Act to maintain compliance and improve patient care. The current healthcare environment demands that stakeholders adopt new technologies like AI and automation to enhance processes and achieve the Act’s goals for better patient outcomes through improved efficiency and data access.
Simbo is making doctors' and patients' lives better. Connect now to know more.
Schedule Demo Now© Since 2019, Simbo AI.
